Endeavor

EndeavorRx, developed by expert neuroscientists and award-winning game designers, is a revolutionary video game treatment that has been FDA-authorized to improve attention in children between the ages of 8-12, diagnosed with primarily attentive or combined-type ADHD. This game's pharmacological access requires a prescription from a healthcare provider. On receiving a prescription for EndeavorRx, our reliable pharmacy partner, PhilRx, will provide an activation code to initiate the treatment. Powered by exclusive Selective Stimulus Management Engine (SSME™) technology, the EndeavorRx game challenges the brain areas that play a crucial role in maintaining attention functionality. EndeavorRx aims to improve your child's cognitive function, ability to focus, and potential to comprehend. This interactive game encourages kids to successfully navigate their character through different hurdles, collect targets while avoiding obstacles. The players chase mystical creatures, run through various worlds, use power-ups to solve problems, and build their universe. In line with each child's performance, the difficulty levels of the game adjust in real-time. EndeavorRx Insight®, the official Akili companion app, helps caregivers to monitor their child's treatment progress for the EndeavorRx game effectively. The app offers a free consultation on EndeavorRx treatment solutions by reliably connecting to the child's treatment; the app provides daily reports of in-game completion and effort scores. Download the app today from the app store! EndeavorRx is a digital therapeutic that enhances attention function by reducing attention deficits in children aged between 8-12 years with primarily inattentive or combined-type ADHD and having a history of attention issues. The game has been shown to enhance a digitally assessed measure (Test of Variables of Attention, T.O.V.A) of sustained and selective attention in individuals who engage with it. The game does not substitute the child's medication or serve as a stand-alone therapeutic. It is recommended that clinicians evaluate therapy, medication, educational programs, and any other therapeutic approach that addresses the symptoms of attention deficit disorder. Most children who played the game during EndeavorRx clinical trials experienced frustration due to game challenges; however, no adverse effects were observed. EndeavorRx is exclusively accessible for children with a prescription from a healthcare provider. Parents are advised to review the game's guidelines, cautions, and precautions, which are detailed in the Instructions for Use, before deciding to use EndeavorRx. Visit https://www.endeavorrx.com/instructions-for-use/. It is recommended that children play EndeavorRx for 25 minutes a day, 5 days a week, for at least four consecutive weeks or based on the healthcare provider's instructions. After four weeks of treatment, it is possible that children will benefit from additional treatment, as directed by the healthcare provider. If your child has any side effects such as frustration, headache, dizziness, emotional reaction, nausea, or aggression while playing EndeavorRx, stop the game's treatment and contact your healthcare provider before resuming. Patients with color blindness, photo-sensitive epilepsy, or physical limitations should consult their healthcare provider or caregivers to determine whether EndeavorRx is appropriate. EndeavorRx.com is an excellent source of information, providing insights and useful information that can help anyone interested in ADHD treatment. EndeavorRx, Endeavor, Akili Care, ADHD Insight, Insight, EndeavorRx Insight, SSME, Play Your Medicine, and Akili Assist, including the logos, are trademarks or registered trademarks of Akili Interactive Labs, Inc. Other trademarks belong to their respective owners. Patent protection is available for EndeavorRx, as specified in the applicable Terms of Use. Please see the following web pages for additional information: Terms of Use: https://my.akili.care/terms Privacy Notice: https://my.akili.care/privacy